Chiron Announces Termination of SEC Investigation
07 2월 2006 - 10:00PM
Business Wire
Chiron Corporation (Nasdaq:CHIR) today announced that the staff of
the Securities and Exchange Commission (SEC) has decided to
terminate its investigation of whether Chiron violated any federal
securities laws in connection with the previous suspension by the
UK Medicines and Healthcare products Regulatory Agency (MHRA) of
Chiron's license to manufacture FLUVIRIN(R) influenza virus vaccine
and has ended its inquiry into the company's restatement of
financial results for the second and third quarters of 2004. Chiron
has been informed that no enforcement action has been recommended
against the company in connection with these matters. About Chiron
Chiron delivers innovative and valuable products to protect human
health by advancing pioneering science across the landscape of
biotechnology. The company works to deliver on the limitless
promise of science and make a positive difference in people's
lives. For more information about Chiron, please visit
www.chiron.com.
Chiron (NASDAQ:CHIR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Chiron (NASDAQ:CHIR)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024